Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MICB Genetic Variants and Its Protein Soluble Level Are Associated with the Risk of Chronic GvHD and CMV Infection after Allogeneic HSCT. | Arch Immunol Ther Exp (Warsz) | 2024 | 38847554 | PubTator, text mining | PubMed |
| A multi-ethnic reference panel to impute HLA classical and non-classical class I alleles in admixed samples: Testing imputation accuracy in an admixed sample from Brazil. | HLA | 2024 | 38837862 | PubTator, text mining | PubMed |
| Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers. | Front Immunol | 2024 | 38835753 | PubTator, text mining | PubMed |
| Nanobody-based CAR NK cells for possible immunotherapy of MICA+ tumors. | PNAS Nexus | 2024 | 38756234 | PubTator, text mining | PubMed |
| Soluble MIC-A, IPI, and response to treatment strongly predict survival in patients with germinal center diffuse large B cell lymphoma. | Eur J Haematol | 2024 | 38742655 | PubTator, text mining | PubMed |
| Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands. | Int J Mol Sci | 2024 | 38731936 | PubTator, text mining | PubMed |
| Proteomic analysis reveals potential therapeutic targets for childhood asthma through Mendelian randomization. | Clin Transl Allergy | 2024 | 38730525 | PubTator, text mining | PubMed |
| Efficacy of Pembrolizumab and Biomarker Analysis in Patients with WGS-Based Intermediate to High Tumor Mutational Load: Results from the Drug Rediscovery Protocol. | Clin Cancer Res | 2024 | 38630551 | PubTator, text mining | PubMed |
| Pan-inhibition of the three H2S synthesizing enzymes restrains tumor progression and immunosuppression in breast cancer. | Cancer Cell Int | 2024 | 38627665 | PubTator, text mining | PubMed |
| Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells. | Cell Rep | 2024 | 38619967 | PubTator, text mining | PubMed |
| A novel MICA/B-targeted chimeric antigen receptor augments the cytotoxicity of NK cells against tumor cells. | Biochem Biophys Res Commun | 2024 | 38598902 | PubTator, text mining | PubMed |
| Characterisation of RAET1E/ULBP4 exon 4 and 3' untranslated region genetic architecture reveals further diversity and allelic polymorphism. | HLA | 2024 | 38575368 | PubTator, text mining | PubMed |
| MICA-specific nanobodies for diagnosis and immunotherapy of MICA+ tumors. | Front Immunol | 2024 | 38550583 | PubTator, text mining | PubMed |
| Identifying Proteins and Amino Acids Associated with Liver Cancer Risk: A Study Utilizing Mendelian Randomization and Bulk RNA Sequencing Analysis. | J Pers Med | 2024 | 38541004 | PubTator, text mining | PubMed |
| Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy. | Int J Mol Sci | 2024 | 38473926 | PubTator, text mining | PubMed |
| Targeting NKG2D/NKG2DL axis in multiple myeloma therapy. | Cytokine Growth Factor Rev | 2024 | 38378397 | PubTator, text mining | PubMed |
| Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies. | Cytometry B Clin Cytom | 2024 | 38345160 | PubTator, text mining | PubMed |
| Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity. | Heliyon | 2024 | 38293535 | PubTator, text mining | PubMed |
| Macrophage barrier in the tumor microenvironment and potential clinical applications. | Cell Commun Signal | 2024 | 38279145 | PubTator, text mining | PubMed |
| TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress. | Mol Biol Rep | 2024 | 38270700 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=8